BOSTON & MONTREAL, November 25, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene"), a clinical-stage, non-viral genetic ...
The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...
TipRanks on MSN
CG Oncology initiated with a Buy at Truist
Truist analyst Gregory Renza initiated coverage of CG Oncology (CGON) with a Buy rating and $62 price target The firm views Creto’s high complete ...
A significant communication gap exists between NMIBC patients and providers, with only 18% having regular discussions about ...
Systemic immunotherapy is emerging as a bladder-sparing option for NMIBC, especially for patients unresponsive to BCG therapy ...
The addition of atezolizumab to BCG did not yield improved EFS compared with BCG alone in patients with high-risk ...
ADVANCED-2 (NCT05951179) is a Phase 2 open-label trial assessing intravesical TARA-002 in NMIBC patients with carcinoma in situ or CIS (± Ta/T1) who are Bacillus Calmette-Guérin (BCG)-Unresponsive ...
In a new study published in Horticulture Research, a team of researchers from the Institute of Subtropical Agriculture of the ...
A supervised exercise program helped patients with advanced breast cancer live longer, according to a study presented at the Advanced Breast Cancer Conference.
Initiated rolling Biologics License Application (BLA) submission to U.S. FDA for cretostimogene monotherapy in high-risk (HR) BCG-unresponsive ...
B. cereus is common in the environment. It can be present in soil and therefore on vegetation. That means it can come into ...
To nobody's surprise, this is yet another exaggerated topic that's gone viral. However, since many people meal prep for the week with rice or other grains as part of a healthy muscle-building or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback